White matter microstructure and cognitive function in young women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 1, 2016, Pages 314-323

  Rees, D Aled ^a   Udiawar, Maneesh ^a,b   Berlot, Rok ^c,d   Jones, Derek K ^b   O'Sullivan, Michael J ^b,d  

^a Maurice Wohl Clinical Neuroscience Institute   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

ACADEMIC ACHIEVEMENT; ADULT; AGE; ARTICLE; BODY MASS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COGNITION; COGNITION ASSESSMENT; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONATION; FUNCTIONAL MORPHOLOGY; HUMAN; INSULIN RESISTANCE; INTELLIGENCE; MENTAL PERFORMANCE; MORBIDITY; NEUROANATOMY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; WHITE MATTER; YOUNG ADULT; ADOLESCENT; BLOOD; COMPLICATION; GRAY MATTER; INTELLIGENCE TEST; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PSYCHOLOGY; ULTRASTRUCTURE;

ADOLESCENT; ADULT; ANDROGENS; BODY MASS INDEX; COGNITION; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; FEMALE; GRAY MATTER; HUMANS; INSULIN RESISTANCE; INTELLIGENCE TESTS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYCYSTIC OVARY SYNDROME; WHITE MATTER; YOUNG ADULT;

EID: 84954518314     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2318     Document Type: Article

References (34)

1. Tan ZS, Beiser AS, Fox CS, et al. Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: The Framingham Offspring Study. Diabetes Care. 2011;34:1766-1770.
2. Tolppanen AM, Ngandu T, Kåreholt I, et al. Midlife and late-life body mass index and late-life dementia: Results from a prospective population-based cohort. J Alzheimers Dis. 2014;38:201-209.
3. Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: A population-based twin study. Neurology. 2011;76:1568-1574.
4. Puurunen J, Piltonen T, Morin-Papunen L, et al. Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. J Clin Endocrinol Metab. 2011;96: 1827-1834.
5. Barnard L, Balen AH, Ferriday D, Tiplady B, Dye L. Cognitive functioning in polycystic ovary syndrome. Psychoneuroendocrinology. 2007;32:906-914.
6. Schattmann L, Sherwin BB. Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women. Horm Behav. 2007;51:587-596.
7. Reijmer YD, Brundel M, de Bresser J, et al. Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: A diffusion tensor imaging study. Diabetes Care. 2013;36:137-144.
8. Yau PL, Javier DC, Ryan CM, et al. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia. 2010;53:2298-2306.
9. Aye T, Barnea-Goraly N, Ambler C, et al. White matter structural differences in young children with type 1 diabetes: A diffusion tensor imaging study. Diabetes Care. 2012;35:267-273.
10. Metzler-Baddeley C, Baddeley RJ, Jones DK, Aggleton JP, O'Sullivan MJ. Individual differences in fornix microstructure and body mass index. PLoS One. 2013;8:e59849.
11. Stanek KM, Strain G, Devlin M, et al. Body mass index and neurocognitive functioning across the adult lifespan. Neuropsychology. 2013;27:141-151.
12. Xu J, Li Y, Lin H, Sinha R, PotenzaMN.Body mass index correlates negatively with white matter integrity in the fornix and corpus callosum: A diffusion tensor imaging study. Human Brain Mapp. 2013; 34:1044-1052.
13. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81:19-25.
14. Watson S, Blundell HL, Evans WD, Griffiths H, Newcombe RG, Rees DA. Can abdominal bioelectrical impedance refine the determination of visceral fat from waist circumference? Physiol Meas. 2009;30:N53-N58.
15. Reijmer YD, van den Berg E, Ruis C, Kappelle LJ, Biessels GJ. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Rev. 2010;26:507-519.
16. Gunstad J, Lhotsky A, Wendell CR, Ferrucci L, Zonderman AB. Longitudinal examination of obesity and cognitive function: Results from the Baltimore longitudinal study of aging. Neuroepidemiology. 2010;34:222-229.
17. Grober E, Buschke H, Crystal H, Bang S, Dresner R. Screening for dementia by memory testing. Neurology. 1988;38:900-903.
18. Jones DK, Horsfield MA, Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med. 1999;42:515-525.
19. Leemans A, Jeurissen B, Sijbers J, Jones DK. ExploreDTI: A graphical toolbox for processing, analyzing, and visualizing diffusionMR data. Proceedings of the ISMRM 17th Annual Meeting, Honolulu, HI, 2009 (p.3536).
20. Berlot R, Metzler-Baddeley C, Jones DK, O'Sullivan MJ. CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment. NeuroImage. 2014;92:27-35.
21. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. 1996. J Magn Reson. 2011;213:560-570.
22. Smith SM, Jenkinson M, Johansen-Berg H, et al. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. NeuroImage. 2006;31:1487-1505.
23. Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE. Permutation inference for the general linear model. NeuroImage. 2014;92:381-397.
24. Smith SM, Nichols TE. Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage. 2009;44:83-98.
25. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745-2749.
26. Morgan CL, Jenkins-Jones S, Currie CJ, Rees DA. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: A retrospective, observational study. J Clin Endocrinol Metab. 2012;97:3251-3260.
27. Barry JA, Parekh HS, Hardiman PJ. Visual-spatial cognition in women with polycystic ovarian syndrome: The role of androgens. Hum Reprod. 2013;28:2832-2837.
28. Kumar R, Chavez AS, Macey PM, Woo MA, Harper RM. Brain axial and radial diffusivity changes with age and gender in healthy adults. Brain Res. 2013;1512:22-36.
29. Liu F, Vidarsson L, Winter JD, Tran H, Kassner A. Sex differences in the human corpus callosum microstructure: A combined T2 myelin-water and diffusion tensor magnetic resonance imaging study. Brain Res. 2010;1343:37-45.
30. Mueller K, Horstmann A, Moller HE, et al. Obesity associated cerebral gray and white matter alterations are interrelated in the female brain. PLoS One. 2014;9:e114206.
31. Mueller K, Anwander A, Moller HE, et al. Sex-dependent influences of obesity on cerebral white matter investigated by diffusion-tensor imaging. PLoS One. 2011;6:e18544.
32. Jones DK, Knösche TR, Turner R. White matter integrity, fiber count, and other fallacies: The do's and don'ts of diffusion MRI. Neuroimage. 2013;73:239-254.
33. Qizilbash N, Gregson J, JohnsonME,et al.BMIand risk of dementia in two million people over two decades: A retrospective cohort study. Lancet Diabetes Endocrinol. 2015;3:431-436.
34. Schattmann L, Sherwin BB. Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: A randomized, placebo-controlled treatment study. Horm Behav. 2007;51:579-586.